Wells Fargo & Company Mirati Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$41.99 - $62.38 $5.83 Million - $8.66 Million	-138,782 Reduced 93.49%	9,665 $567,000
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $1.11 Million - $1.8 Million	39,774 Added 36.6%	148,447 $6.47 Million
Q2 2023 Aug 15, 2023	BUY	$36.13 - $49.49 $242,323 - $331,929	6,707 Added 6.58%	108,673 $3.93 Million
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $1.03 Million - $1.54 Million	28,324 Added 38.46%	101,966 $3.79 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $328,756 - $785,606	7,966 Added 12.13%	73,642 $3.34 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $276,199 - $402,461	-4,642 Reduced 6.6%	65,676 $4.59 Million
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $828,077 - $1.88 Million	-21,146 Reduced 23.12%	70,318 $4.72 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $2.16 Million - $4.31 Million	28,547 Added 45.37%	91,464 $7.52 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $29.4 Million - $42.4 Million	-223,065 Reduced 78.0%	62,917 $9.23 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $5.26 Million - $7.07 Million	-39,830 Reduced 12.22%	285,982 $50.6 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $284,688 - $355,326	1,977 Added 0.61%	325,812 $52.6 Million
Q1 2021 May 13, 2021	BUY	$158.92 - $221.61 $3.75 Million - $5.22 Million	23,569 Added 7.85%	323,835 $55.5 Million
Q4 2020 Feb 09, 2021	BUY	$162.05 - $240.27 $14.5 Million - $21.6 Million	89,787 Added 42.66%	300,266 $66 Million
Q3 2020 Nov 05, 2020	BUY	$113.26 - $167.27 $17.2 Million - $25.4 Million	151,780 Added 258.57%	210,479 $35 Million
Q2 2020 Aug 13, 2020	BUY	$72.01 - $120.39 $962,413 - $1.61 Million	13,365 Added 29.48%	58,699 $6.7 Million
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $3.16 Million - $5.27 Million	45,334 New	45,334 $3.49 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account